HTG Molecular Diagnostics, Inc. Conversion of Stock, Amount Converted
HTG Molecular Diagnostics, Inc. reported Conversion of Stock, Amount Converted of $2.42 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountConverted1 · last filed 2022-03-29
- HTG Molecular Diagnostics, Inc. conversion of stock, amount converted for the quarter ending 2020-12-31 was $0.00.
- HTG Molecular Diagnostics, Inc. conversion of stock, amount converted for the quarter ending 2020-09-30 was $0.00.
- HTG Molecular Diagnostics, Inc. conversion of stock, amount converted for the quarter ending 2020-06-30 was $0.00.
- HTG Molecular Diagnostics, Inc. conversion of stock, amount converted for the quarter ending 2020-03-31 was $2.42M.
- HTG Molecular Diagnostics, Inc. conversion of stock, amount converted for fiscal 2020 was $2.42M.
| Period end | Conversion of Stock, Amount Converted 3 month | Conversion of Stock, Amount Converted 6 month | Conversion of Stock, Amount Converted 9 month | Conversion of Stock, Amount Converted 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | $0.00 derived: sum of 3 quarters · filed 2022-03-29 | $2.42M 10-K · filed 2022-03-29 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $2.42M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.42M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $2.42M 10-Q · filed 2021-05-13 |